Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2010:2

Review

Published on 16 Mar 2010

DOI: 10.4137/CMRT.S1600


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




What Your Colleagues Say About Libertas Academica
I am very impressed with the professional editorial team at Libertas Academica. They have my highest recommendation.
Dr Jimmy Efird (East Carolina University, NC, USA)
More Testimonials

Quick Links


New article and journal news notification services